Indication
Ornithine carbamoyltransferase deficiency
Ornithine carbamoyltransferase deficiency is an X-linked inborn error of metabolism and the most common disorder of the urea cycle. Read more about Ornithine carbamoyltransferase deficiency
41 drugs 28 manufacturers
Drugs that treat it
Common Ornithine carbamoyltransferase deficiency therapies.
SODIUM PHENYLBUTYRATE
AMMONUL (sodium benzoate/sodium phenylacetate)
BUPHENYL (sodium phenylbutyrate)
BUPHENYL (sodium phenylbutyrate)
RAVICTI (glycerol phenylbutyrate)
PHEBURANE (sodium phenylbutyrate)
OLPRUVA (sodium phenylbutyrate)
BUPHENYL (sodium phenylbutyrate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonOrnithine carbamoyltransferase deficiency is an X-linked inborn error of metabolism and the most common disorder of the urea cycle.
It is caused by pathogenic variants in the *OTC* gene, leading to deficient mitochondrial ornithine carbamoyltransferase activity and the failure to convert carbamoyl phosphate and ornithine into citrulline.
This enzymatic block primarily affects the hepatic urea cycle and central nervous system, resulting in the systemic accumulation of neurotoxic ammonia and excessive urinary excretion of orotic acid.
Clinical manifestations range from catastrophic neonatal hyperammonemic encephalopathy, lethargy, seizures, and coma in hemizygous males to late-onset episodic confusion, psychiatric disturbances, or developmental delay across childhood and adulthood in individuals with partial enzyme deficiency or skewed X-inactivation.
- nih.gov
Ornithine carbamoyltransferase deficiency is an X-linked inborn error of metabolism and the most common disorder of the urea cycle This enzymatic block primarily affects the hepatic urea cycle and central nervous system, resulting in the systemic accumulation of neurotoxic ammonia and excessive urinary excretion of orotic acid Clinical manifestations range from catastrophic neonatal hyperammonemic encephalopathy, lethargy, seizures, and coma in hemizygous males to late-onset episodic confusion, ...
- nih.gov
Ornithine carbamoyltransferase deficiency is an X-linked inborn error of metabolism and the most common disorder of the urea cycle This enzymatic block primarily affects the hepatic urea cycle and central nervous system, resulting in the systemic accumulation of neurotoxic ammonia and excessive urinary excretion of orotic acid Clinical manifestations range from catastrophic neonatal hyperammonemic encephalopathy, lethargy, seizures, and coma in hemizygous males to late-onset episodic confusion, ...
- nih.gov
Ornithine carbamoyltransferase deficiency is an X-linked inborn error of metabolism and the most common disorder of the urea cycle It is caused by pathogenic variants in the *OTC* gene, leading to deficient mitochondrial ornithine carbamoyltransferase activity and the failure to convert carbamoyl phosphate and ornithine into citrulline
- nih.gov
It is caused by pathogenic variants in the *OTC* gene, leading to deficient mitochondrial ornithine carbamoyltransferase activity and the failure to convert carbamoyl phosphate and ornithine into citrulline
- medlineplus.gov
This enzymatic block primarily affects the hepatic urea cycle and central nervous system, resulting in the systemic accumulation of neurotoxic ammonia and excessive urinary excretion of orotic acid
Personalize your experience
Follow Ornithine carbamoyltransferase deficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.